FOGSI recommends administering Covid-19 vaccines to pregnant, breastfeeding women

The Federation of Obstetricians and Gynaecologists Society of India has recommended that obstetricians and gynaecologists and women’s healthcare providers should be allowed to administer Covid-19 vaccines to pregnant and breastfeeding women with preparations to manage adverse events.

But they said that individual practitioners cannot advise vaccination to pregnant and lactating women in India until there is a change in recommendations from the MOHFW, GOI.

FOGSI has acknowledged that there is limited data available on the use of Covid-19 vaccines in pregnancy, especially of the vaccines available in India.

“However, there is a need to prevent further waves and the vaccine is the best and long term solution to this. This protection should extend to pregnant and lactating women. The very real benefits of vaccinating pregnant and lactating women seem to far outweigh any theoretical and remote risks of vaccination,” FOGSI chairperson Dr Alpesh Gandhi has said.

– Stay updated with the latest Pune news. Follow Express Pune on Twitter here and on Facebook here. You can also join our Express Pune Telegram channel here.

Data from basic science and animal studies has not shown any adverse fetal or neonatal effects of the vaccine.

“As matters stand in our country, every individual needs protection from the surging Covid-19 infections. We are in the midst of the second wave. Lactating women should also be considered as Covid vaccine candidates as there are no known adverse effects on the neonate who is breastfeeding. In fact, there is a passage of protective antibodies to the child, which may be a beneficial effect. The method of administering and monitoring the vaccine and the schedule of vaccination should be the same for pregnant and lactating women as for the general population,” FOGSI said in a statement on Friday.

International professional bodies have taken a uniformly positive stand on the Covid-19 vaccine in pregnancy and lactation.

These statements are based on the ratio of potential benefits and risks of the vaccine versus the disease in a given geographic area. At present, it is believed that the risk of getting Covid-19 in pregnancy and its resulting morbidity is much more than the theoretical risks from the vaccine.

The first study conducted on vaccination in pregnant and lactating women was published last month in the USA. The study showed that Covid-19 vaccination generates a robust immune response in pregnant and lactating women, equivalent to the general population. Additionally, protective antibodies were also isolated in umbilical cord blood and breast milk, implying protection to the fetus and newborn. This data pertains to 131 women who were vaccinated with the mRNA vaccine. At present, there is no data on immunisation of pregnant and lactating women with Covishield or Covaxin.

Experts at FOGSI based their statement considering the density of population and current infection rates in the country, a substantial increase in the incidence and severity of Covid-19 infection in pregnant women in recent times, risk of infection in pregnancy complicating routine pregnancy care and delivery, risk of serious morbidity with infection in pregnancy (even though most pregnant women will have a mild course), demonstrated efficacy of the vaccines available in India and efficient rollout in the country and experience of decades of vaccine administration in pregnancy with vaccines for other diseases.

Dr Rajeshwari Pawar, senior consultant obstetrician at Motherhood hospital, Kharadi, said couples who are planning a pregnancy should consult their gynaecologist before deciding on the vaccination.